135 related articles for article (PubMed ID: 34670707)
1. Correlation Between Serum Amyloid A and Antibody Response to West Nile Virus Vaccine Antigen in Healthy Horses.
Skipper L; Pusterla N
J Equine Vet Sci; 2021 Nov; 106():103755. PubMed ID: 34670707
[TBL] [Abstract][Full Text] [Related]
2. A West Nile virus (WNV) recombinant canarypox virus vaccine elicits WNV-specific neutralizing antibodies and cell-mediated immune responses in the horse.
El Garch H; Minke JM; Rehder J; Richard S; Edlund Toulemonde C; Dinic S; Andreoni C; Audonnet JC; Nordgren R; Juillard V
Vet Immunol Immunopathol; 2008 Jun; 123(3-4):230-9. PubMed ID: 18372050
[TBL] [Abstract][Full Text] [Related]
3. Comparative efficacies of three commercially available vaccines against West Nile Virus (WNV) in a short-duration challenge trial involving an equine WNV encephalitis model.
Seino KK; Long MT; Gibbs EP; Bowen RA; Beachboard SE; Humphrey PP; Dixon MA; Bourgeois MA
Clin Vaccine Immunol; 2007 Nov; 14(11):1465-71. PubMed ID: 17687109
[TBL] [Abstract][Full Text] [Related]
4. Investigation of antigen specific lymphocyte responses in healthy horses vaccinated with an inactivated West Nile virus vaccine.
Davis EG; Zhang Y; Tuttle J; Hankins K; Wilkerson M
Vet Immunol Immunopathol; 2008 Dec; 126(3-4):293-301. PubMed ID: 18838173
[TBL] [Abstract][Full Text] [Related]
5. Protection of horses from West Nile virus Lineage 2 challenge following immunization with a whole, inactivated WNV lineage 1 vaccine.
Bowen RA; Bosco-Lauth A; Syvrud K; Thomas A; Meinert TR; Ludlow DR; Cook C; Salt J; Ons E
Vaccine; 2014 Sep; 32(42):5455-9. PubMed ID: 25131745
[TBL] [Abstract][Full Text] [Related]
6. A recombinant fusion protein consisting of West Nile virus envelope domain III fused in-frame with equine CD40 ligand induces antiviral immune responses in horses.
Liu SA; Haque M; Stanfield B; Andrews FM; Roy AA; Kousoulas KG
Vet Microbiol; 2017 Jan; 198():51-58. PubMed ID: 28062007
[TBL] [Abstract][Full Text] [Related]
7. Serum neutralising antibody titres against a lineage 2 neuroinvasive West Nile Virus strain in response to vaccination with an inactivated lineage 1 vaccine in a European endemic area.
Fehér O; Bakonyi T; Barna M; Nagy A; Takács M; Szenci O; Joó K; Sárdi S; Korbacska-Kutasi O
Vet Immunol Immunopathol; 2020 Sep; 227():110087. PubMed ID: 32629300
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of Cross-Protection of a Lineage 1 West Nile Virus Inactivated Vaccine against Natural Infections from a Virulent Lineage 2 Strain in Horses, under Field Conditions.
Chaintoutis SC; Diakakis N; Papanastassopoulou M; Banos G; Dovas CI
Clin Vaccine Immunol; 2015 Sep; 22(9):1040-9. PubMed ID: 26178384
[TBL] [Abstract][Full Text] [Related]
9. Efficacy, duration, and onset of immunogenicity of a West Nile virus vaccine, live Flavivirus chimera, in horses with a clinical disease challenge model.
Long MT; Gibbs EP; Mellencamp MW; Bowen RA; Seino KK; Zhang S; Beachboard SE; Humphrey PP
Equine Vet J; 2007 Nov; 39(6):491-7. PubMed ID: 18065305
[TBL] [Abstract][Full Text] [Related]
10. West Nile virus-specific immunoglobulin isotype responses in vaccinated and infected horses.
Khatibzadeh SM; Gold CB; Keggan AE; Perkins GA; Glaser AL; Dubovi EJ; Wagner B
Am J Vet Res; 2015 Jan; 76(1):92-100. PubMed ID: 25535666
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the efficacy provided by a Recombinant Canarypox-Vectored Equine West Nile Virus vaccine against an experimental West Nile Virus intrathecal challenge in horses.
Siger L; Bowen R; Karaca K; Murray M; Jagannatha S; Echols B; Nordgren R; Minke JM
Vet Ther; 2006; 7(3):249-56. PubMed ID: 17039448
[TBL] [Abstract][Full Text] [Related]
12. Live-attenuated recombinant equine herpesvirus type 1 (EHV-1) induces a neutralizing antibody response against West Nile virus (WNV).
Rosas CT; Tischer BK; Perkins GA; Wagner B; Goodman LB; Osterrieder N
Virus Res; 2007 Apr; 125(1):69-78. PubMed ID: 17241683
[TBL] [Abstract][Full Text] [Related]
13. The anamnestic serologic response to vaccination with a canarypox virus-vectored recombinant West Nile virus (WNV) vaccine in horses previously vaccinated with an inactivated WNV vaccine.
Grosenbaugh DA; Backus CS; Karaca K; Minke JM; Nordgren RM
Vet Ther; 2004; 5(4):251-7. PubMed ID: 15719324
[TBL] [Abstract][Full Text] [Related]
14. Safety of an attenuated West Nile virus vaccine, live Flavivirus chimera in horses.
Long MT; Gibbs EP; Mellencamp MW; Zhang S; Barnett DC; Seino KK; Beachboard SE; Humphrey PP
Equine Vet J; 2007 Nov; 39(6):486-90. PubMed ID: 18065304
[TBL] [Abstract][Full Text] [Related]
15. Equine vaccine for West Nile virus.
Ng T; Hathaway D; Jennings N; Champ D; Chiang YW; Chu HJ
Dev Biol (Basel); 2003; 114():221-7. PubMed ID: 14677692
[TBL] [Abstract][Full Text] [Related]
16. Assessment of the efficacy of a single dose of a recombinant vaccine against West Nile virus in response to natural challenge with West Nile virus-infected mosquitoes in horses.
Siger L; Bowen RA; Karaca K; Murray MJ; Gordy PW; Loosmore SM; Audonnet JC; Nordgren RM; Minke JM
Am J Vet Res; 2004 Nov; 65(11):1459-62. PubMed ID: 15566080
[TBL] [Abstract][Full Text] [Related]
17. Serologic response to West Nile virus vaccination in the greater one-horned rhinoceros (Rhinoceros unicornis).
Wolf TM; Gandolf AR; Dooley JL; Atkinson MW; Wolfe BA
J Zoo Wildl Med; 2008 Dec; 39(4):537-41. PubMed ID: 19110693
[TBL] [Abstract][Full Text] [Related]
18. Investigation of an outbreak of encephalomyelitis caused by West Nile virus in 136 horses.
Ward MP; Levy M; Thacker HL; Ash M; Norman SK; Moore GE; Webb PW
J Am Vet Med Assoc; 2004 Jul; 225(1):84-9. PubMed ID: 15239478
[TBL] [Abstract][Full Text] [Related]
19. Immunological response in horses following West Nile virus vaccination with inactivated or recombinant vaccine.
Monaco F; Purpari G; Di Gennaro A; Mira F; Di Marco P; Guercio A; Savini G
Vet Ital; 2019 Mar; 55(1):73-79. PubMed ID: 30951184
[TBL] [Abstract][Full Text] [Related]
20. Advanced oxidation technology for the development of a next-generation inactivated West Nile virus vaccine.
Quintel BK; Thomas A; Poer DeRaad DE; Slifka MK; Amanna IJ
Vaccine; 2019 Jul; 37(30):4214-4221. PubMed ID: 30606462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
